DiaCarta's QuantiVirusTMSARS-CoV-2 Test
Manufactured by Next Pharma Inc., Canada - nextpharmainc.com/
Device identification number
295
CE Marking
✓Yes
HSC common list (RAT)
×No
Format
Manual
Target type
Nucleic acid
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Assay Type
Nucleic acid-PCR
Method
RT-PCR
Time
120 minutes
Clinical Sensitivity
96.7 %
Clinical Specificity
100 %
Notes
http://nextpharmainc.com/
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements